# FDA recall D-1349-2022

> **Amerisource Health Services LLC** · Class III · drug recall initiated 2022-07-27.

## Product

Azacitidine for Injection, 100 mg Lyophilized Powder, Single-Dose Vials, Rx Only, Manufactured by:  Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 India.  Manufactured for BluePoint Laboratories.  NDC 68001-0313-56

## Reason for recall

Subpotent Drug

## Distribution

Nationwide within the USA

## Key facts

- **Recall number:** D-1349-2022
- **Recalling firm:** Amerisource Health Services LLC
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-07-27
- **Report date:** 2022-08-24
- **Termination date:** 2023-09-28

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Columbus, OH, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1349-2022

## Citation

> AI Analytics. FDA recall D-1349-2022. Retrieved 2026-07-19 from https://api.ai-analytics.org/recall/D-1349-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*